EDINBURGH, SCOTLAND - JUNE 29, 2022 - Blackford, the platform for medical imaging applications and AI, and Us2.ai today announced their partnership to bring advanced echocardiography analysis tools to the...
News & Events
Upcoming Events.
07.01.2022
Biomedical Advanced Research & Development Authority (BARDA) Accelerator Network Collaborative Virtual Series
Art Pappas will be participating in BARDA's Accelerator Network C…
Location
virtual
Chiesi Ventures Fund portfolio company Aura Biosciences Receives FDA Fast Track Designation for Belzupacap Sarotalocan (AU-011) for the Treatment of Non-Muscle Invasive Bladder Cancer - https://www.businesswire.com/news/home/20220630005254/en/Aura-Biosciences-Receives-FDA-Fast-Track-Designation-for-Belzupacap-Sarotalocan-AU-011-for-the-Treatment-of-Non-Muscle-Invasive-Bladder-Cancer?utm_campaign=shareaholic&utm_medium=twitter&utm_source=socialnetwork
Pappas Asia Innovation Fund portfolio company http://Us2.ai announces partnership with Blackford for advanced echo interpretation http://story.cd/AATfd8 via @PRWeb
Art Pappas will be participating on a panel titled "Scale your Company via Strategic Partnerships & Venture Financing" on July 1st from 12:00-1:30 PM EDT as part of BARDA's "Bench to BARDA - Accelerator Collaborative Series." https://www.eventbrite.com/e/bench-to-barda-accelerator-collaborative-series-tickets-338385398837?aff=estw&utm-campaign=social&utm-content=attendeeshare&utm-medium=discovery&utm-source=tw&utm-term=listing @Eventbrite
Pappas Capital is proud to support the North Carolina Biotechnology Center's efforts to help expand and promote life sciences manufacturing in North Carolina.
https://wraltechwire.com/2022/06/19/north-carolina-is-taking-the-next-big-step-as-a-global-life-sciences-leader/
